Prognostic factors

Dermatol Clin. 2002 Oct;20(4):647-58, viii-ix. doi: 10.1016/s0733-8635(02)00027-x.

Abstract

The American Joint Committee on Cancer has recently revised the staging system for melanoma. In this article, prognostic factors for melanoma are discussed in order of significance as outlined by the new staging system. In addition, other historically relevant prognostic factors are reviewed. The article concludes with a discussion of new technology, which may aid in the future staging of melanoma patients.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Biomarkers, Tumor / analysis
  • Biopsy, Needle
  • Female
  • Heterozygote
  • Humans
  • Infant, Newborn
  • Lymphatic Metastasis / pathology*
  • Male
  • Melanoma / epidemiology*
  • Melanoma / genetics
  • Melanoma / pathology*
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Sensitivity and Specificity
  • Sex Distribution
  • Skin Neoplasms / epidemiology*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology*
  • Survival Analysis

Substances

  • Biomarkers, Tumor